Cannabidiol and palmitoylethanolamide are anti-inflammatory in the acutely inflamed human colon. 21 Sep Continue reading →
Manipulation of the Endocannabinoid System in Colitis: A Comprehensive Review. 20 Sep Continue reading →
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. 20 Sep Continue reading →
Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. 08 Jul Continue reading →
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes. 08 Jul Continue reading →
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation. 08 Jul Continue reading →